Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for peripheral artery disease
ISRCTN99954716Phase 3Recruiting
- Sponsor
- University of Bristol
- Start
- May 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of colchicine in arteriosclerosis obliterans, sponsored by University of Bristol. Started May 2021; status: recruiting.
02
Drugs
colchicine
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on ISRCTN99954716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN99954716.